Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Johnson & Johnson

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Log in to access your PharmaMiles and download the data

    Company name Country Product name DMF review Review date Pay date DMF number Submission Status Type
    Johnson & Johnson Innovative Medicine
    U.S.A
    		 ALFENTANIL HYDROCHLORIDE N/A 11337 1995-02-03 Inactive II
    Johnson & Johnson Innovative Medicine
    U.S.A
    		 ALTANSERIN TARTRATE (CODE NO. R 53200) N/A 5637 1984-12-14 Inactive II